Alzheimer’s Prevention Initiative: a proposal to evaluate presymptomatic treatments as quickly as possible

Brain imaging in the presymptomatic detection, tracking and prevention of Alzheimer's disease

(2009) Eric M. Reiman   Alzheimers & Dementia

Prevent Alzheimer's disease by 2020: A national strategic goal

(2009) Zaven S. Khachaturian et al.   Alzheimers & Dementia

2009 Alzheimer's disease facts and figures

(2009)   Alzheimers & Dementia

CSF Biomarkers

(2009) Niklas Mattsson et al.   Annals of the New York Academy of Sciences

Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels

(2009) Holly D. Soares et al.   Annals of the New York Academy of Sciences

Influence of Cognitive Status, Age, and APOE-4 Genetic Risk on Brain FDDNP Positron-Emission Tomography Imaging in Persons Without Dementia

(2009) Gary W. Small et al.   ARCHIVES OF GENERAL PSYCHIATRY

Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease

(2009) John C. Morris et al.   ARCHIVES OF NEUROLOGY

Physical Activity, Diet, and Risk of Alzheimer Disease

(2009) Nikolaos Scarmeas   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Early structural changes in individuals at risk of familial Alzheimer’s disease: a volumetry and magnetization transfer MR imaging study

(2009) A. Ginestroni et al.   JOURNAL OF NEUROLOGY

Preclinical Properties of 18F-AV-45: A PET Agent for A  Plaques in the Brain

(2009) S. R. Choi et al.   JOURNAL OF NUCLEAR MEDICINE

Evolution of Aβ42 and Aβ40 levels and Aβ42/Aβ40 ratio in plasma during progression of Alzheimer’s disease: A multicenter assessment

(2009) K. Blennow et al.   Journal of Nutrition Health & Aging

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

(2009) Jessica B.S. Langbaum et al.   NEUROIMAGE

Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging

(2009) Eric M. Reiman et al.   NEUROIMAGE

Fibrillar amyloid-  burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

(2009) E. M. Reiman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Distinct patterns of brain activity in young carriers of the APOE- 4 allele

(2009) N. Filippini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease

(2009) M. Britschgi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium

(2008) Zaven S. Khachaturian et al.   Alzheimers & Dementia

Commentary on “A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium”

(2008) Eric R. Siemers et al.   Alzheimers & Dementia

Commentary on “A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium.” An impending prevention clinical trial for Alzheimer's disease: Roadmaps and realities

(2008) Allen D. Roses   Alzheimers & Dementia

Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)

(2008)   ARCHIVES OF NEUROLOGY

Blood Protein Signature for the Early Diagnosis of Alzheimer Disease

(2008) Markus Britschgi   ARCHIVES OF NEUROLOGY

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

(2008) Clifford R. Jack et al.   BRAIN

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

(2008) Milos D. Ikonomovic et al.   BRAIN

Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease

(2008) Nicola T. Lautenschlager et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study

(2008) M D M Haag et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

(2008) Christopher C Rowe et al.   LANCET NEUROLOGY

List of Drugs in Development for Neurodegenerative Diseases

(2008) Vanda Pogačić et al.   Neurodegenerative Diseases

Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions

(2008) Eric M. Reiman et al.   NEUROIMAGE

Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers

(2008) A.C. Burggren et al.   NEUROIMAGE

No advantage of A 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies

(2008) C. A. Szekely et al.   NEUROLOGY

Hypometabolism and Altered Cerebrospinal Fluid Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints

(2007) Lisa Mosconi et al.   BIOLOGICAL PSYCHIATRY

The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease

(2007) Lidia Glodzik-Sobanska et al.   NEUROBIOLOGY OF AGING

Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E ɛ4

(2006) Thomas Espeseth et al.   NEUROBIOLOGY OF AGING